Dergiler / Medicine Science / 2013 / Cilt: 2 Sayı: 4

Lack of Association of Insulin Receptor Substrate Gene Polymorphisms with Obstructive Sleep Apnea Syndrome

Sayfa
830–841
Yayın Tarihi
2013-12-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Besides, there was no association between IRS-1 and IRS-2 polymorphisms and HOMA in OSAS.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Sleep apnea syndrome is associated with increased prevalence of diabetes and has recently shown to be associated with insulin resistance.
📊
Temel Bulgular & Veri:The aim of the present study was to investigate the relationships between insulin resistance, insulin receptor substrate-1 (IRS-1), insulin receptor substrate-2 (IRS-2) gene polymorphisms and obstructive sleep apnea syndrome (OSAS).
💡
Sonuç & Katkı:Besides, there was no association between IRS-1 and IRS-2 polymorphisms and HOMA in OSAS.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Obstructive sleep apnea syndrome · insulin receptor substrate-1 gene polymorphism · insulin receptor substrate-2 gene polymorphism

Abstract

Sleep apnea syndrome is associated with increased prevalence of diabetes and has recently shown to be associated with insulin resistance. The aim of the present study was to investigate the relationships between insulin resistance, insulin receptor substrate-1 (IRS-1), insulin receptor substrate-2 (IRS-2) gene polymorphisms and obstructive sleep apnea syndrome (OSAS). The study population consisted of 56 consecutive patients with OSAS and 26 subjects without OSAS were enrolled in the study. Genotyping of IRS-1 and IRS-2 were amplified by polymerase chain reaction (PCR). Insulin resistance was estimated using the homeostasis model assessment (HOMA). In OSAS patients, 2 (3.6%) had G972R gene polymorphism and 54 (96.4%) had no nucleotide substitution in IRS-1 gene whereas in the control group, there was no nucleotide substitution in IRS-1 gene (p>0.05). Besides, 47 OSAS patients (84.0%) had no nucleotide substitution, 3 (5.3%) had G1057D heterozygous, 1 (1.8%) had P1033P heterozygous, 3 (5.3%) had P1033P homozygous and 2 (3.6%) had P1033P heterozygous/G1057D heterozygous polymorphisms in IRS-2 gene. In the control subjects, 21 (80.8%) had no nucleotide substitution, 3 (11.5%) had P1033P homozygous and 2 (7.7%) had P1033P heterozygous polymorphisms in IRS-2 gene (p>0.05). There was no significant difference between two groups in terms of fasting glucose and HOMA-IR. It was observed that IRS-1 and IRS-2 gene polymorphisms didnt increase risk for OSAS. Besides, there was no association between IRS-1 and IRS-2 polymorphisms and HOMA in OSAS.

🔖

Bu Makaleye Atıf Yap

Sarac, F., Berdeli, A., Basoglu, Ö. K., Savas, S., Atan, M., Akcicek, F. (2013). Lack of Association of Insulin Receptor Substrate Gene Polymorphisms with Obstructive Sleep Apnea Syndrome. Medicine Science, Cilt: 2 Sayı: 4, 830–841. https://ajindex.com/articles/1003338

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Ronksley PE, Hemmelgarn BR, Heitman SJ, Flemons WW, Ghali WA, Manns B, Faris P, Tsai WH. Excessive daytime sleepiness is associated with increased health care utilization among patients referred for assessment of OSA. Sleep. 2011;34(3):363-70.
  2. Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet. 2009;373(9657):82-93.
  3. Riha RL, McNicholas WT. The genetic and cardiovascular aspects of obstructive sleep apnoea/hypopnoea syndrome. Eur Respir J. 2009;33(2):233-6.
  4. Kent BD, Ryan S, McNicholas WT. The genetics of obstructive sleep apnoea. Curr Opin Pulm Med. 2010;16(6):536-42.
  5. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med.2005;172(2):1590-5.
  6. Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med. 2009;122(12):1122-7.
  7. Polotsky VY, Patil SP, Savransky V, Laffan A, Fonti S, Frame LA, Steele KE, Schweizter MA, Clark JM, Torbenson MS, Schwartz AR. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity. Am J Respir Crit Care Med. 2009;179(3):228-4.
  8. Hribal ML, Federici M, Porzio O, Lauro D, Borboni P, Accili D, Lauro R, Sesti G. The Gly-->Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells. J Clin Endocrinol Metab. 2000;85(5):2004-13.
  9. Ura S, Araki E, Kishikawa H, Shirotani T, Todaka M, Isami S, Shimoda S, Yoshimura R, Matsuda K, Motoyoshi S, Miyamura N, Kahn CR, Shichiri M. Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: identification of five novel polymorphisms. Diabetologia. 1996;39(5):600-8.
  10. Laakso M, Malkki M, Kekäläinen P, Kuusisto J, Deeb SS. Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J Clin Invest. 1994;94(3):1141-6.
  11. Porzio O, Federici M, Hribal ML, Lauro D, Accili D, Lauro R, Borboni P, Sesti G. The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. J Clin Invest. 1999;104(3):357-64.
  12. Mammarella S, Romano F, Di Valerio A, Creati B, Esposito DL, Palmirotta R, Capani F, Vitullo P, Volpe G, Battista P, Della Loggia F, Mariani-Costantini R, Cama A. Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes. Hum Mol Genet. 2000;9(17):2517-21. Johns MW. A new method for measuring daytime sleepines